Join
Live feed
·
PRReleasevia Quantisnow
Longeveron Inc. logo

New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer's Disease Accepted for Poster Presentation at the 2026 Alzheimer's Association International Conference (AAIC)

ByQuantisnow·Wall Street's wire, on your screen.
LGVN· Longeveron Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LGVN (Longeveron Inc.) and more on Quantisnow.